SlideShare a Scribd company logo
Scaling up testing
The role of HIV self-testing
Karen Champenois
Research Department,
Maison Blanche Hospital,
Paris, France
Definition of HIV self-test
• HIV rapid test performed by the user
– Sampling
– Process
– Interpretation of the result
• Whole / finger-stick blood or oral fluid
sample
• Any positive result should be confirmed
by another testing according to a
national validated algorithm
Source: F. Simon
HIVST available in UK (April 2015)
Lab: Nazeing
www.autotest-sante.com
HIVST available in France (September 2015)
Instructions for use
HIVST available in France (January 2017)
Lab : BiolLytical
Test stand
Test DevicePouched
Device
Pouched
Developer Vial
Stepwise
Instructions
Pre & Post-Test
Informational Booklet
Package Insert
HIVST available in USA (October 2012)
Policy and implementation of HIVST
HIVST – pros & cons: accuracy
Pros
• Sensitivity
– Blood test > oral fluid test
(96.4%- 98.8%) > (65.0%-97.9%)
• Specificity ~ 100%
• Invalid test (<5%)
– Blood test > oral fluid test
Cons
• Low sensitivity in early infections
• Window period of 3 months
• Increased rate of false negative
tests when people are on ART
– Implication for PrEP
Pant Pai et al. Plos One 2013; Figueroa et al. AIDS Conference 2016; Pavie et al. Plos One 2010;
Suntharasamai et al. Plos one 2015
HIVST – pros & cons: acceptability
Pros
• High acceptability up to 98%
• Preference
– HIVST > conventional testing
– Oral fluid > blood sample
• Confidentiality, convenience,
immediacy
Cons
• Remaining concerns
– Lack of counseling
– Risk of handling error
– Test reliability
Pant pai et al. Plos One 2013; Figueroa et al. AIDS Behav 2015; Greacen et al. AIDS care 2012
HIVST – pros & cons: side effects
Pros
• Enhance autonomy,
empowerment
– Controling one’s health choice
– Reducing at risk behaviour
• Reduce barriers as stigma
Cons
• Self-harm
• Uncertain access to information,
counseling and care
• Social harm
– Intimate partner violence
– Coercive testing
Figueroa et al. AIDS Behav 2015; Brown et al. AIDS Behav 2014; Carballo-Diéguez et al.
AIDS and Behav 2012
HIVST – pros & cons: access
Pros
• Large availability
– Pharmacies
– Internet
– Over the counter approaches
• Privacy
Cons
• Actual accessibility
• Internet : numerous tests of
questionable quality
• Price
– €28 / £30 / US$40
≠ socially vulnerable populations
Figueroa et al. AIDS Behav 2015; Myers et al. AIDS Behav 2016;
Values and preferences
of key populations in France
• MSM
– Accuracy and reliability of tests. Preference for blood-based HIVST
– HIVST as a prevention tool (repeated testing), used in a context of risk behaviour
• Migrants from Sub-Saharan Africa
– Security for using HIVST
– Benefit to know HIV status and free access to care regardless the administrative
situation
– Communication tool adapted (color, shape, …)
• PWID
– Implication of service providing specific health care and substance misuse
community organisations
• Transgender people
– HIV testing is not the health priority
HIVST: expected to increase uptake and frequency of
HIV testing mainly in key populations
 Encouraging first results
• In France, MSM the most interested in HIVST were those who
‒ live their sexual life with men in the absolute secrecy
‒ had never been tested
• In NL, HIVST succeeded in reaching first-time and infrequent testing population
• In USA, using ads on Grindr increased the HIVST uptake in MSM
• In USA and Australia, 2 RCTs showed an increase in testing frequency in MSM in
the HIVST arm
• Lack of evidence remains
‒ Reduction of the time period between infection and diagnosis
‒ Linkage to care after a HIVST in high income country
Greacen et al. AIDS Care 2012; Zuure et al. AIDS Conference 2016; Huang AIDS Prev 2016;
Rosengren et al. Sex Health 2016; Katz et al. IAS 2015; Jamil et al. AIDS conference 2016
As conclusion
• WHO new guidelines
HIV self-testing should
be offered as an
additional approach to
HIV testing services
(strong recommendation,
moderate quality evidence)
Available at http://www.who.int/hiv/pub/vct/hiv-self-testing-guidelines/en/
Thank you for your attention
15
SlideF.Larue
Fast-track the end of AIDS in the EU
practical evidence-based interventions

More Related Content

What's hot

Fast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in EuropeFast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in Europe
European Centre for Disease Prevention and Control
 
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
European Centre for Disease Prevention and Control
 
Priorities for fast tracking the end of AIDS in Europe: Community perspective
Priorities for fast tracking the end of AIDS in Europe: Community perspectivePriorities for fast tracking the end of AIDS in Europe: Community perspective
Priorities for fast tracking the end of AIDS in Europe: Community perspective
European Centre for Disease Prevention and Control
 
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
European Centre for Disease Prevention and Control
 
HIV among migrants, what do we know?
HIV among migrants, what do we know?HIV among migrants, what do we know?
HIV among migrants, what do we know?
European Centre for Disease Prevention and Control
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
ReShape
 
HCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckHCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel Peck
ReShape
 
PrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overviewPrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overview
European Centre for Disease Prevention and Control
 
HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe
European Centre for Disease Prevention and Control
 
Hepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham CookeHepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham Cooke
ReShape
 
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
UC San Diego AntiViral Research Center
 
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
Office of HIV Planning
 
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 202103.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
UC San Diego AntiViral Research Center
 
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Office of HIV Planning
 
Wesat2105
Wesat2105Wesat2105
Wesat2105
Mohamed Rafique
 
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
StopTb Italia
 
Self-testing for HIV: initial experience of the UK’s first kit
Self-testing for HIV: initial experience of the UK’s first kitSelf-testing for HIV: initial experience of the UK’s first kit
Self-testing for HIV: initial experience of the UK’s first kit
Carmen Figueroa
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
UC San Diego AntiViral Research Center
 
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
UC San Diego AntiViral Research Center
 
04.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 202004.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 2020
UC San Diego AntiViral Research Center
 

What's hot (20)

Fast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in EuropeFast-tracking the end of AIDS in Europe
Fast-tracking the end of AIDS in Europe
 
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
HIV Continuum of Care in the EU/EEA: Findings from Dublin Declaration monitor...
 
Priorities for fast tracking the end of AIDS in Europe: Community perspective
Priorities for fast tracking the end of AIDS in Europe: Community perspectivePriorities for fast tracking the end of AIDS in Europe: Community perspective
Priorities for fast tracking the end of AIDS in Europe: Community perspective
 
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
Are EU/EEA countries ready to monitor progress on hepatitis C programmes?
 
HIV among migrants, what do we know?
HIV among migrants, what do we know?HIV among migrants, what do we know?
HIV among migrants, what do we know?
 
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
Testing Strategies for HIV and HCV: similarities and differences - Dr Chloe O...
 
HCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel PeckHCV Treatment Access across Europe - Raquel Peck
HCV Treatment Access across Europe - Raquel Peck
 
PrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overviewPrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overview
 
HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe HIV: epidemiological challenges in Europe
HIV: epidemiological challenges in Europe
 
Hepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham CookeHepatitis C Research Gaps - Graham Cooke
Hepatitis C Research Gaps - Graham Cooke
 
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
 
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
Kathleen Brady - HIV in Philadelphia (Annual Epidemiological Presentation)
 
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 202103.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
 
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
Kathleen Brady Philadelphia HIV Epidemiologic Update 2015
 
Wesat2105
Wesat2105Wesat2105
Wesat2105
 
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
PPT Castelli "Dall'HIV all'AIDS fino alla coinfezione: una diagnosi difficile?"
 
Self-testing for HIV: initial experience of the UK’s first kit
Self-testing for HIV: initial experience of the UK’s first kitSelf-testing for HIV: initial experience of the UK’s first kit
Self-testing for HIV: initial experience of the UK’s first kit
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
 
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
 
04.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 202004.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 2020
 

Viewers also liked

Fast-track the end of AIDS global
Fast-track the end of AIDS globalFast-track the end of AIDS global
Fast-track the end of AIDS global
European Centre for Disease Prevention and Control
 
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
European Centre for Disease Prevention and Control
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
European Centre for Disease Prevention and Control
 
ECDC 2016 activities 2016 and 2017 priorities: ENVI Committee, European Parli...
ECDC 2016 activities 2016 and 2017 priorities: ENVI Committee, European Parli...ECDC 2016 activities 2016 and 2017 priorities: ENVI Committee, European Parli...
ECDC 2016 activities 2016 and 2017 priorities: ENVI Committee, European Parli...
European Centre for Disease Prevention and Control
 
HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...
HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...
HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...
European Centre for Disease Prevention and Control
 
ECDC – TESSy data access policy, Gaetan Guyodo (ECDC)
ECDC – TESSy data access policy, Gaetan Guyodo (ECDC)ECDC – TESSy data access policy, Gaetan Guyodo (ECDC)
ECDC – TESSy data access policy, Gaetan Guyodo (ECDC)
European Centre for Disease Prevention and Control
 
Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...
Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...
Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...
European Centre for Disease Prevention and Control
 
Germaine Hanquet: Indirect effect of infant PCV10/13 vaccination on IPD in th...
Germaine Hanquet: Indirect effect of infant PCV10/13 vaccination on IPD in th...Germaine Hanquet: Indirect effect of infant PCV10/13 vaccination on IPD in th...
Germaine Hanquet: Indirect effect of infant PCV10/13 vaccination on IPD in th...
European Centre for Disease Prevention and Control
 
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
European Centre for Disease Prevention and Control
 
What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVWhat Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
European Centre for Disease Prevention and Control
 
HIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEAHIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEA
European Centre for Disease Prevention and Control
 
HIV prevention and control - the EU is up to the challenge
HIV prevention and control - the EU is up to the challengeHIV prevention and control - the EU is up to the challenge
HIV prevention and control - the EU is up to the challenge
European Centre for Disease Prevention and Control
 
Joacim Rocklöv: What scenarios for the epidemiological pattern of Zika infect...
Joacim Rocklöv: What scenarios for the epidemiological pattern of Zika infect...Joacim Rocklöv: What scenarios for the epidemiological pattern of Zika infect...
Joacim Rocklöv: What scenarios for the epidemiological pattern of Zika infect...
European Centre for Disease Prevention and Control
 
HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015
European Centre for Disease Prevention and Control
 
HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015
European Centre for Disease Prevention and Control
 
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015 World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
European Centre for Disease Prevention and Control
 

Viewers also liked (16)

Fast-track the end of AIDS global
Fast-track the end of AIDS globalFast-track the end of AIDS global
Fast-track the end of AIDS global
 
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...How can HIV among men who have sex with men be prevented in Europe? Evidence-...
How can HIV among men who have sex with men be prevented in Europe? Evidence-...
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
 
ECDC 2016 activities 2016 and 2017 priorities: ENVI Committee, European Parli...
ECDC 2016 activities 2016 and 2017 priorities: ENVI Committee, European Parli...ECDC 2016 activities 2016 and 2017 priorities: ENVI Committee, European Parli...
ECDC 2016 activities 2016 and 2017 priorities: ENVI Committee, European Parli...
 
HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...
HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...
HIV, drugs and risk behaviour in Europe – what have we learnt and what are th...
 
ECDC – TESSy data access policy, Gaetan Guyodo (ECDC)
ECDC – TESSy data access policy, Gaetan Guyodo (ECDC)ECDC – TESSy data access policy, Gaetan Guyodo (ECDC)
ECDC – TESSy data access policy, Gaetan Guyodo (ECDC)
 
Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...
Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...
Camelia Savulescu: PCV13 effectiveness and overall effect of PCV10/13 vaccina...
 
Germaine Hanquet: Indirect effect of infant PCV10/13 vaccination on IPD in th...
Germaine Hanquet: Indirect effect of infant PCV10/13 vaccination on IPD in th...Germaine Hanquet: Indirect effect of infant PCV10/13 vaccination on IPD in th...
Germaine Hanquet: Indirect effect of infant PCV10/13 vaccination on IPD in th...
 
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
 
What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVWhat Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
 
HIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEAHIV and AIDS surveillance in the EU/EEA
HIV and AIDS surveillance in the EU/EEA
 
HIV prevention and control - the EU is up to the challenge
HIV prevention and control - the EU is up to the challengeHIV prevention and control - the EU is up to the challenge
HIV prevention and control - the EU is up to the challenge
 
Joacim Rocklöv: What scenarios for the epidemiological pattern of Zika infect...
Joacim Rocklöv: What scenarios for the epidemiological pattern of Zika infect...Joacim Rocklöv: What scenarios for the epidemiological pattern of Zika infect...
Joacim Rocklöv: What scenarios for the epidemiological pattern of Zika infect...
 
HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015HIV AIDS Surveillance Report 2015
HIV AIDS Surveillance Report 2015
 
HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015HIV infection in children and adolescents in the EU/EEA 2015
HIV infection in children and adolescents in the EU/EEA 2015
 
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015 World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
World Tuberculosis Day 2017 - Tuberculosis situation in the EU/EEA, 2015
 

Similar to Scaling up HIV testing: the role of self-testing

HIVST and PrEP community consultation
HIVST and PrEP community consultationHIVST and PrEP community consultation
HIVST and PrEP community consultation
Carmen Figueroa
 
Realizing the potential for HIV self-testing - a summary of latest evidence
Realizing the potential for HIV self-testing - a summary of latest evidenceRealizing the potential for HIV self-testing - a summary of latest evidence
Realizing the potential for HIV self-testing - a summary of latest evidence
Cheryl Johnson
 
Overview of HIV self-testing
Overview of HIV self-testingOverview of HIV self-testing
Overview of HIV self-testing
Carmen Figueroa
 
WHO - BMGF_HIVST overview_feb 24 RB
WHO - BMGF_HIVST overview_feb 24 RBWHO - BMGF_HIVST overview_feb 24 RB
WHO - BMGF_HIVST overview_feb 24 RB
SlidesShare_Foxtrot
 
WHO - BMGF_HIVST overview_feb 24 RB
WHO - BMGF_HIVST overview_feb 24 RBWHO - BMGF_HIVST overview_feb 24 RB
WHO - BMGF_HIVST overview_feb 24 RB
Cheryl Johnson
 
PrEP: Research update and implementation program in NSW
PrEP: Research update and implementation program in NSWPrEP: Research update and implementation program in NSW
PrEP: Research update and implementation program in NSW
Australian Federation of AIDS Organisations
 
PrEP E-Learning Discussion I
PrEP E-Learning Discussion I PrEP E-Learning Discussion I
PrEP E-Learning Discussion I
JSI
 
Where are we on HIV testing services - the achievements and the gaps
Where are we on HIV testing services - the achievements and the gapsWhere are we on HIV testing services - the achievements and the gaps
Where are we on HIV testing services - the achievements and the gaps
Cheryl Johnson
 
Routine HIV Testing in the Community Health Center
Routine HIV Testing in the Community Health CenterRoutine HIV Testing in the Community Health Center
Routine HIV Testing in the Community Health Center
MPCA
 
PITC Presentation by MSD
PITC Presentation by MSDPITC Presentation by MSD
PITC Presentation by MSD
freespirit7
 
Integrating HIV Prevention into Primary Care
Integrating HIV Prevention into Primary CareIntegrating HIV Prevention into Primary Care
Integrating HIV Prevention into Primary Care
CHC Connecticut
 
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSFamily Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
Nikole Gettings
 
PrEP overview -- AIDS2018 -- July 2018 -- Baeten.pptx
PrEP overview -- AIDS2018 -- July 2018 -- Baeten.pptxPrEP overview -- AIDS2018 -- July 2018 -- Baeten.pptx
PrEP overview -- AIDS2018 -- July 2018 -- Baeten.pptx
NeomalMarambe1
 
Partners Demonstration Project - HIV self testing update - Feb 2015
Partners Demonstration Project - HIV self testing update - Feb 2015Partners Demonstration Project - HIV self testing update - Feb 2015
Partners Demonstration Project - HIV self testing update - Feb 2015
SlidesShare_Foxtrot
 
Partners Demonstration Project - HIV self testing update - Feb 2015
Partners Demonstration Project - HIV self testing update - Feb 2015Partners Demonstration Project - HIV self testing update - Feb 2015
Partners Demonstration Project - HIV self testing update - Feb 2015
Cheryl Johnson
 
0. 2016 WHO ART Guidelines_General Overview.pptx
0. 2016 WHO ART Guidelines_General Overview.pptx0. 2016 WHO ART Guidelines_General Overview.pptx
0. 2016 WHO ART Guidelines_General Overview.pptx
yakemichael
 
HIV self-testing
HIV self-testingHIV self-testing
Oral PrEP E-learning: Discussion Session 1
Oral PrEP E-learning: Discussion Session 1Oral PrEP E-learning: Discussion Session 1
Oral PrEP E-learning: Discussion Session 1
JSI
 
State of the science halkitis
State of the science halkitisState of the science halkitis
State of the science halkitis
healthhiv
 
Antiretroviral therapy for pregnant women living with HIV or hepatitis B: Wha...
Antiretroviral therapy for pregnant women living with HIV or hepatitis B: Wha...Antiretroviral therapy for pregnant women living with HIV or hepatitis B: Wha...
Antiretroviral therapy for pregnant women living with HIV or hepatitis B: Wha...
Health Evidence™
 

Similar to Scaling up HIV testing: the role of self-testing (20)

HIVST and PrEP community consultation
HIVST and PrEP community consultationHIVST and PrEP community consultation
HIVST and PrEP community consultation
 
Realizing the potential for HIV self-testing - a summary of latest evidence
Realizing the potential for HIV self-testing - a summary of latest evidenceRealizing the potential for HIV self-testing - a summary of latest evidence
Realizing the potential for HIV self-testing - a summary of latest evidence
 
Overview of HIV self-testing
Overview of HIV self-testingOverview of HIV self-testing
Overview of HIV self-testing
 
WHO - BMGF_HIVST overview_feb 24 RB
WHO - BMGF_HIVST overview_feb 24 RBWHO - BMGF_HIVST overview_feb 24 RB
WHO - BMGF_HIVST overview_feb 24 RB
 
WHO - BMGF_HIVST overview_feb 24 RB
WHO - BMGF_HIVST overview_feb 24 RBWHO - BMGF_HIVST overview_feb 24 RB
WHO - BMGF_HIVST overview_feb 24 RB
 
PrEP: Research update and implementation program in NSW
PrEP: Research update and implementation program in NSWPrEP: Research update and implementation program in NSW
PrEP: Research update and implementation program in NSW
 
PrEP E-Learning Discussion I
PrEP E-Learning Discussion I PrEP E-Learning Discussion I
PrEP E-Learning Discussion I
 
Where are we on HIV testing services - the achievements and the gaps
Where are we on HIV testing services - the achievements and the gapsWhere are we on HIV testing services - the achievements and the gaps
Where are we on HIV testing services - the achievements and the gaps
 
Routine HIV Testing in the Community Health Center
Routine HIV Testing in the Community Health CenterRoutine HIV Testing in the Community Health Center
Routine HIV Testing in the Community Health Center
 
PITC Presentation by MSD
PITC Presentation by MSDPITC Presentation by MSD
PITC Presentation by MSD
 
Integrating HIV Prevention into Primary Care
Integrating HIV Prevention into Primary CareIntegrating HIV Prevention into Primary Care
Integrating HIV Prevention into Primary Care
 
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MSFamily Planning for Persons Living with HIVAIDS_2015 AR and MS
Family Planning for Persons Living with HIVAIDS_2015 AR and MS
 
PrEP overview -- AIDS2018 -- July 2018 -- Baeten.pptx
PrEP overview -- AIDS2018 -- July 2018 -- Baeten.pptxPrEP overview -- AIDS2018 -- July 2018 -- Baeten.pptx
PrEP overview -- AIDS2018 -- July 2018 -- Baeten.pptx
 
Partners Demonstration Project - HIV self testing update - Feb 2015
Partners Demonstration Project - HIV self testing update - Feb 2015Partners Demonstration Project - HIV self testing update - Feb 2015
Partners Demonstration Project - HIV self testing update - Feb 2015
 
Partners Demonstration Project - HIV self testing update - Feb 2015
Partners Demonstration Project - HIV self testing update - Feb 2015Partners Demonstration Project - HIV self testing update - Feb 2015
Partners Demonstration Project - HIV self testing update - Feb 2015
 
0. 2016 WHO ART Guidelines_General Overview.pptx
0. 2016 WHO ART Guidelines_General Overview.pptx0. 2016 WHO ART Guidelines_General Overview.pptx
0. 2016 WHO ART Guidelines_General Overview.pptx
 
HIV self-testing
HIV self-testingHIV self-testing
HIV self-testing
 
Oral PrEP E-learning: Discussion Session 1
Oral PrEP E-learning: Discussion Session 1Oral PrEP E-learning: Discussion Session 1
Oral PrEP E-learning: Discussion Session 1
 
State of the science halkitis
State of the science halkitisState of the science halkitis
State of the science halkitis
 
Antiretroviral therapy for pregnant women living with HIV or hepatitis B: Wha...
Antiretroviral therapy for pregnant women living with HIV or hepatitis B: Wha...Antiretroviral therapy for pregnant women living with HIV or hepatitis B: Wha...
Antiretroviral therapy for pregnant women living with HIV or hepatitis B: Wha...
 

More from European Centre for Disease Prevention and Control

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
European Centre for Disease Prevention and Control
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
European Centre for Disease Prevention and Control
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
European Centre for Disease Prevention and Control
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
European Centre for Disease Prevention and Control
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
European Centre for Disease Prevention and Control
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
European Centre for Disease Prevention and Control
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
European Centre for Disease Prevention and Control
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
European Centre for Disease Prevention and Control
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
European Centre for Disease Prevention and Control
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
European Centre for Disease Prevention and Control
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
European Centre for Disease Prevention and Control
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
European Centre for Disease Prevention and Control
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
European Centre for Disease Prevention and Control
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
European Centre for Disease Prevention and Control
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
European Centre for Disease Prevention and Control
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
European Centre for Disease Prevention and Control
 

More from European Centre for Disease Prevention and Control (20)

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Respondent Driven Sampling
 
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
 

Recently uploaded

The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 

Recently uploaded (20)

The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 

Scaling up HIV testing: the role of self-testing

  • 1. Scaling up testing The role of HIV self-testing Karen Champenois Research Department, Maison Blanche Hospital, Paris, France
  • 2. Definition of HIV self-test • HIV rapid test performed by the user – Sampling – Process – Interpretation of the result • Whole / finger-stick blood or oral fluid sample • Any positive result should be confirmed by another testing according to a national validated algorithm Source: F. Simon
  • 3. HIVST available in UK (April 2015) Lab: Nazeing
  • 4. www.autotest-sante.com HIVST available in France (September 2015) Instructions for use
  • 5. HIVST available in France (January 2017) Lab : BiolLytical
  • 6. Test stand Test DevicePouched Device Pouched Developer Vial Stepwise Instructions Pre & Post-Test Informational Booklet Package Insert HIVST available in USA (October 2012)
  • 8. HIVST – pros & cons: accuracy Pros • Sensitivity – Blood test > oral fluid test (96.4%- 98.8%) > (65.0%-97.9%) • Specificity ~ 100% • Invalid test (<5%) – Blood test > oral fluid test Cons • Low sensitivity in early infections • Window period of 3 months • Increased rate of false negative tests when people are on ART – Implication for PrEP Pant Pai et al. Plos One 2013; Figueroa et al. AIDS Conference 2016; Pavie et al. Plos One 2010; Suntharasamai et al. Plos one 2015
  • 9. HIVST – pros & cons: acceptability Pros • High acceptability up to 98% • Preference – HIVST > conventional testing – Oral fluid > blood sample • Confidentiality, convenience, immediacy Cons • Remaining concerns – Lack of counseling – Risk of handling error – Test reliability Pant pai et al. Plos One 2013; Figueroa et al. AIDS Behav 2015; Greacen et al. AIDS care 2012
  • 10. HIVST – pros & cons: side effects Pros • Enhance autonomy, empowerment – Controling one’s health choice – Reducing at risk behaviour • Reduce barriers as stigma Cons • Self-harm • Uncertain access to information, counseling and care • Social harm – Intimate partner violence – Coercive testing Figueroa et al. AIDS Behav 2015; Brown et al. AIDS Behav 2014; Carballo-Diéguez et al. AIDS and Behav 2012
  • 11. HIVST – pros & cons: access Pros • Large availability – Pharmacies – Internet – Over the counter approaches • Privacy Cons • Actual accessibility • Internet : numerous tests of questionable quality • Price – €28 / £30 / US$40 ≠ socially vulnerable populations Figueroa et al. AIDS Behav 2015; Myers et al. AIDS Behav 2016;
  • 12. Values and preferences of key populations in France • MSM – Accuracy and reliability of tests. Preference for blood-based HIVST – HIVST as a prevention tool (repeated testing), used in a context of risk behaviour • Migrants from Sub-Saharan Africa – Security for using HIVST – Benefit to know HIV status and free access to care regardless the administrative situation – Communication tool adapted (color, shape, …) • PWID – Implication of service providing specific health care and substance misuse community organisations • Transgender people – HIV testing is not the health priority
  • 13. HIVST: expected to increase uptake and frequency of HIV testing mainly in key populations  Encouraging first results • In France, MSM the most interested in HIVST were those who ‒ live their sexual life with men in the absolute secrecy ‒ had never been tested • In NL, HIVST succeeded in reaching first-time and infrequent testing population • In USA, using ads on Grindr increased the HIVST uptake in MSM • In USA and Australia, 2 RCTs showed an increase in testing frequency in MSM in the HIVST arm • Lack of evidence remains ‒ Reduction of the time period between infection and diagnosis ‒ Linkage to care after a HIVST in high income country Greacen et al. AIDS Care 2012; Zuure et al. AIDS Conference 2016; Huang AIDS Prev 2016; Rosengren et al. Sex Health 2016; Katz et al. IAS 2015; Jamil et al. AIDS conference 2016
  • 14. As conclusion • WHO new guidelines HIV self-testing should be offered as an additional approach to HIV testing services (strong recommendation, moderate quality evidence) Available at http://www.who.int/hiv/pub/vct/hiv-self-testing-guidelines/en/
  • 15. Thank you for your attention 15
  • 17. Fast-track the end of AIDS in the EU practical evidence-based interventions